BCM
REPL icon

Bayesian Capital Management’s Replimune Group REPL Stock Holding History

Bayesian Capital Management’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-23,975
Closed -$263K – 941
2024
Q3 		$263K Buy
+23,975
New +$244K 0.03% 507

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Bayesian Capital Management's REPL Position: Q4 2024 in Review

Bayesian Capital Management sold out of Replimune Group (REPL) in Q4 2024, closing a stake of 23,975 shares — an estimated $263K sold.

Bayesian Capital Management first reported a position in REPL in Q3 2024 and held it in 1 quarter. The position peaked at $263K in Q3 2024. 157 funds tracked by Wall St. Rank hold REPL as of Q4 2024.

  • Bayesian Capital Management reported no remaining Replimune Group position as of Q4 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 23,975 Replimune Group shares in Q4 2024, an estimated $263K.
  • Bayesian Capital Management first reported a position in Replimune Group in Q3 2024 and held it in 1 quarter.
  • Bayesian Capital Management's Replimune Group position peaked at $263K in Q3 2024.
  • 157 funds tracked by Wall St. Rank held Replimune Group as of Q4 2024.

Based on Bayesian Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.